Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
2 passages
REFERENCES Poyart C, Wajcman H. Hemolytic anemias due to hemoglobinopathies. Mol Aspects Med 1996; 17:129. OWREN PA. Congenital hemolytic jaundice; the pathogenesis of the hemolytic crisis. Blood 1948; 3:231. Serjeant GR, Serjeant BE, Thomas PW, et al. Human parvovirus infection in homozygous sickle cell disease. Lancet 1993; 341:1237. Liesveld JL, Rowe JM, Lichtman MA. Variability of the erythropoietic response in autoimmune hemolytic anemia: analysis of 109 cases. Blood 1987; 69:820. Erslev AJ. Reticulocyte enumeration. In: Williams' Hematology, 5th ed, Beutler E, Lichtman MA, Coller BS, et al. (Eds), McGraw-Hill, New York 1995. p.L28. Red blood cell diseases: Red cell production, red cell indices, and the reticulocyte count. In: Hematology. A Pathophysiological Approach, Babior BM, Stossel TP (Eds), Churchill Livingstone, New York 1984. p.13. Jacobasch G, Rapoport SM. Hemolytic anemias due to erythrocyte enzyme deficiencies. Mol Aspects Med 1996; 17:143. Bossi D, Russo M. Hemolytic anemias due to disorders of red cell membrane skeleton. Mol Aspects Med 1996; 17:171. van Wijk R, van Solinge WW. The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis. Blood 2005; 106:4034. Cazzola M, Beguin Y. New tools for clinical evaluation of erythron function in man. Br J Haematol 1992; 80:278. Bossi D, Giardina B. Red cell physiology. Mol Aspects Med 1996; 17:117. Pimstone NR. Renal degradation of hemoglobin. Semin Hematol 1972; 9:31. Pollycove M. Iron metabolism and kinetics. Semin Hematol 1966; 3:235. Berlin NI, Berk PD. Quantitative aspects of bilirubin metabolism for hematologists. Blood 1981; 57:983. Coburn RF, Williams WJ, White P, Kahn SB. The production of carbon monoxide from hemoglobin in vivo. J Clin Invest 1967; 46:346. Landaw SA. Homeostasis, survival and red cell kinetics: Measurement and imaging of red cell production. In: Hematology. Basic Principles and Practice, 2nd ed, Hoffman R, Benz EJ, Shattil SJ (Eds), Churchill Livingstone, New York 1995. p.448. Ballas SK. Lactate dehydrogenase and hemolysis in sickle cell disease. Blood 2013; 121:243. Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA 1980; 243:1909. Galen RS. Application of the predictive value model in the analysis of test effectiveness. Clin Lab Med 1982; 2:685.
Ballas SK. Lactate dehydrogenase and hemolysis in sickle cell disease. Blood 2013; 121:243. Marchand A, Galen RS, Van Lente F. The predictive value of serum haptoglobin in hemolytic disease. JAMA 1980; 243:1909. Galen RS. Application of the predictive value model in the analysis of test effectiveness. Clin Lab Med 1982; 2:685. Hammerman C, Vreman HJ, Kaplan M, Stevenson DK. Intravenous immune globulin in neonatal immune hemolytic disease: does it reduce hemolysis? Acta Paediatr 1996; 85:1351. Conley CL, Lippman SM, Ness P. Autoimmune hemolytic anemia with reticulocytopenia. A medical emergency. JAMA 1980; 244:1688. Saarinen UM, Chorba TL, Tattersall P, et al. Human parvovirus B19-induced epidemic acute red cell aplasia in patients with hereditary hemolytic anemia. Blood 1986; 67:1411. Diehl LF, Ketchum LH. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 1998; 25:80. Topic 7076 Version 11.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0604-202.43.93.2-49404BB9CF-S244013.14]